Introduction: Scalp inflammation is commonly associated with scalp psoriasis or seborrheic dermatitis. It can aggravate the progression of androgenetic alopecia and cause troublesome itching and burning. Here, we evaluate the efficacy of a shampoo containing 0.075% broad-spectrum cannabidiol in 50 subjects with mild to moderate scalp psoriasis or seborrheic dermatitis. Methods: Inflammation was assessed by evaluating the density of twisted/glomerular or arborizing vessels by trichoscopy using a 6-point scale at baseline and day 14. Symptoms of itching/burning sensation, clinical evaluation of erythema/scaling, overall tolerability, and subject satisfaction were evaluated using 10-point scales. Results: There were significant reductions in arborizing vessel/twisted capillary inflammation and scaling by day 14. Severity scores reduced from 2.3 ± 0.1, 2.6 ± 0.1, and 3.6 ± 0.1, respectively, to 0.5 ± 0.05, 0.8 ± 0.05, and 0.6 ± 0.05 (all p < 0.0001). Symptom scores of itching and burning also reduced significantly from 6.9 ± 0.1 to 4.5 ± 0.1 to 1.5 ± 0.05 and 1.0 ± 0.05 (both p < 0.0001). Severity of erythema and scaling was also significantly reduced from 5.5 ± 0.1 and 7.0 ± 0.1, respectively, to 1.3 ± 0.05 and 1.6 ± 0.05 (both p < 0.0001). Tolerability and subject satisfaction were both excellent. There were no significant differences in treatment effect, tolerability, or subject satisfaction between men and women. Discussion/Conclusion: Replacing current shampooing practices with a broad-spectrum cannabidiol-containing shampoo significantly reduces both severity and symptoms of scalp inflammation within 2 weeks, with excellent tolerability and treatment satisfaction in subjects with mild to moderate scalp psoriasis or seborrheic dermatitis.

1.
Bickers
DR
,
Athar
M
.
Oxidative stress in the pathogenesis of skin disease
.
J Invest Dermatol
.
2006
;
126
(
12
):
2565
75
. .
2.
Trueb
RM
,
Henry
JP
,
Davis
MG
,
Schwartz
JR
.
Scalp condition impacts hair growth and retention via oxidative stress
.
Int J Trichology
.
2018
;
10
(
6
):
262
70
.
3.
Bakry
OA
,
Elshazly
RM
,
Shoeib
MA
,
Gooda
A
.
Oxidative stress in alopecia areata: a case-control study
.
Am J Clin Dermatol
.
2014
;
15
(
1
):
57
64
. .
4.
Yenin
JZ
,
Serarslan
G
,
Yönden
Z
,
Ulutaş
KT
.
Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern
.
Clin Exp Dermatol
.
2015
;
40
(
6
):
617
21
. .
5.
Crowley
J
.
Scalp psoriasis: an overview of the disease and available therapies
.
J Drugs Dermatol
.
2010
;
9
(
8
):
912
8
.
6.
Borda
LJ
,
Wikramanayake
TC
.
Seborrheic dermatitis and dandruff: a comprehensive review
.
J Clin Investig Dermatol
.
2015
;
3
(
2
):
1
22
. .
7.
Lebwohl
MG
,
Bachelez
H
,
Barker
J
,
Girolomoni
G
,
Kavanaugh
A
,
Langley
RG
, et al.
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
.
J Am Acad Dermatol
.
2014
;
70
(
5
):
871
30
. .
8.
Hägg
D
,
Sundström
A
,
Eriksson
M
,
Schmitt-Egenolf
M
.
Severity of psoriasis differs between men and women: a study of the clinical outcome measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish register patients
.
Am J Clin Dermatol
.
2017
;
18
(
4
):
583
90
. .
9.
Sanders
MGH
,
Pardo
LM
,
Franco
OH
,
Ginger
RS
,
Nijsten
T
.
Prevalence and determinants of seborrheic dermatitis in a middle-aged and elderly population: the Rotterdam study
.
Br J Dermatol
.
2018
;
178
(
1
):
148
53
.
10.
Golinska
J
,
Sar-Pomian
M
,
Rudnicka
L
.
Dermoscopic features of psoriasis of the skin, scalp and nails: a systematic review
.
J Eur Acad Dermatol Venereol
.
2019
;
33
(
4
):
648
60
.
11.
Miteva
M
,
Tosti
A
.
Hair and scalp dermatoscopy
.
J Am Acad Dermatol
.
2012
;
67
(
5
):
1040
8
. .
12.
Oláh
A
,
Tóth
BI
,
Borbíró
I
,
Sugawara
K
,
Szöllõsi
AG
,
Czifra
G
, et al.
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
.
J Clin Invest
.
2014
;
124
(
9
):
3713
24
. .
13.
Martinez-Velasco
MA
,
Vazquez-Herrera
NE
,
Tosti
A
.
How to evaluate treatment response in hair diseases in hair and scalp treatments: a practical guide, chapter 20
. In:
Tosti
A
,
Asz-Sigall
D
,
Pirmez
R
, editors.
Springer Verlag
;
2019
. p.
291
322
.
14.
Kim
TW
,
Shim
WH
,
Kim
JM
,
Mun
JH
,
Song
M
,
Kim
HS
, et al.
Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density
.
Ann Dermatol
.
2014
;
26
(
6
):
727
32
.
15.
Jung
GW
,
Ko
HJ
,
Kim
HC
,
Lee
MB
,
Lee
WJ
,
au
SJ
, et al.
Dermoscopy can be useful in differentiating scalp psoriasis from seborrhoeic dermatitis
.
Br J Dermatol
.
2011
;
164
(
3
):
652
6
. .
16.
DeAngelis
YM
,
Gemmer
CM
,
Kaczvinsky
JR
,
Kenneally
DC
,
Schwartz
JR
,
Dawson
TL
 Jr
.
Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity
.
J Investig Dermatol Symp Proc
.
2005
;
10
(
3
):
295
7
. .
17.
Ozturk
P
,
Arican
O
,
Belge Kurutas
E
,
Karakas
T
,
Kabakci
B
.
Oxidative stress in patients with scalp seborrheic dermatitis
.
Acta Dermatovenerol Croat
.
2013
;
21
(
2
):
80
5
.
18.
Schwartz
JR
,
Henry
JP
,
Kerr
KM
,
Mizoguchi
H
,
Li
L
.
The role of oxidative damage in poor scalp health: ramifications to causality and associated hair growth
.
Int J Cosmet Sci
.
2015
;
37
(
Suppl 2
):
9
15
. .
19.
Gomez-Moyano
E
,
Crespo-Erchiga
V
,
Martínez-Pilar
L
,
Godoy Diaz
D
,
Martínez-García
S
,
Lova Navarro
M
, et al.
Do Malassezia species play a role in exacerbation of scalp psoriasis?
J Mycol Med
.
2014
;
24
(
2
):
87
92
. .
20.
Kadam
DP
,
Suryakar
AN
,
Ankush
RD
,
Kadam
CY
,
Deshpande
KH
.
Role of oxidative stress in various stages of psoriasis
.
Indian J Clin Biochem
.
2010
;
25
(
4
):
388
92
. .
21.
Yazici
C
,
Köse
K
,
Utaş
S
,
Tanrikulu
E
,
Taşlidere
N
.
A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress
.
Arch Dermatol Res
.
2016
;
308
(
3
):
207
12
. .
22.
Dimon-Gadal
S
,
Gerbaud
P
,
Thérond
P
,
Guibourdenche
J
,
Anderson
WB
,
Evain-Brion
D
, et al.
Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis
.
J Invest Dermatol
.
2000
;
114
(
5
):
984
9
. .
23.
Bayer
M
,
Mosandl
A
,
Thaçi
D
.
Improved enantioselective analysis of polyunsaturated hydroxy fatty acids in psoriatic skin scales using high-performance liquid chromatography
.
J Chromatogr B Analyt Technol Biomed Life Sci
.
2005
;
819
(
2
):
323
8
. .
24.
Squire
RA
,
Goode
K
.
A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, nizoral) for the treatment of dandruff/seborrhoeic dermatitis
.
J Dermatolog Treat
.
2002
;
13
(
2
):
51
60
. .
25.
Piérard-Franchimont
C
,
Goffin
V
,
Decroix
J
,
Piérard
GE
.
A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis
.
Skin Pharmacol Appl Skin Physiol
.
2002
;
15
(
6
):
434
41
. .
26.
Okokon
EO
,
Verbeek
JH
,
Ruotsalainen
JH
,
Ojo
OA
,
Bakhoya
VN
.
Topical antifungals for seborrhoeic dermatitis
.
Cochrane Database Syst Rev
.
2015
;
5
(
5
):
CD008138
. .
27.
van de Kerkhof
PC
,
Franssen
ME
.
Psoriasis of the scalp. Diagnosis and management
.
Am J Clin Dermatol
.
2001
;
2
(
3
):
159
65
. .
28.
Piérard-Franchimont
C
,
Goffin
V
,
Henry
F
,
Uhoda
I
,
Braham
C
,
Piérard
GE
.
Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations
.
Int J Cosmet Sci
.
2002
;
24
(
5
):
249
56
. .
29.
Choi
FD
,
Juhasz
MLW
,
Atanaskova Mesinkovsks
N
.
Topical ketoconazole: a systematic review of current dermatological applications and future developments
.
J Dermatog Treat
.
2019
;
30
(
8
):
760
71
.
30.
Fischer
TW
,
Herczeg-Lisztes
E
,
Funk
W
,
Zillikens
D
,
Bíró
T
,
Paus
R
.
Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro
.
Br J Dermatol
.
2014
;
171
(
5
):
1031
43
. .
31.
Trueb
RH
.
Serum biotin kevels in women complaining of hair loss
.
Int J Trichology
.
2016
;
8
(
2
):
73
7
.
32.
Nicols
JM
,
Kaplan
BLF
.
Immune responses regulated by cannabidiol
.
Cannabis Cannabinoid Res
.
2002
;
5
(
1
):
12
31
.
33.
Szabó
IL
,
Lisztes
E
,
Béke
G
,
Tóth
KF
,
Paus
R
,
Oláh
A
, et al.
The phytocannabbinoid (-)-cannabidiol operates as a complex, differential modulator of human hair growth: anti-inflammatory submicromolar versus hair growth inhibitory micromolar effects
.
J Invest Dermatol
.
2020
;
140
(
2
):
484
8
.
34.
Derakhshan
N
,
Kazemi
M
.
Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review
.
Curr Clin Pharmacol
.
2016
;
11
(
2
):
146
7
. .
35.
Stander
S
,
Reinhardt
HW
,
Luger
TA
.
Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus
.
Hautarzt
.
2006
;
57
(
9
):
801
7
.
36.
Jordt
SE
,
Bautista
DM
,
Chuang
HH
,
McKemy
DD
,
Zygmunt
PM
,
Högestätt
ED
, et al.
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
.
Nature
.
2004
;
427
(
6971
):
260
5
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.